Literature DB >> 3542350

Lyme disease.

E A Goldings, J Jericho.   

Abstract

Although initially considered a localized epidemic form of arthritis. Lyme disease is now known to have protean manifestation (skin, joint, heart, nervous system) and worldwide distribution. It is caused by infection with the spirochaete Borrelia burgdorferi and is transmitted by a variety of hard ticks and, in some localities, fleas. Antigenic variation between isolates may determine the differences in clinical expression observed between cases in North America and Europe. The reservoir in the animal kingdom is primarily in deer and mice but house pets have also been implicated. The disease is easily treated with oral antibiotics (tetracycline or penicillin) at an early stage but requires parenteral penicillin and can become refractory to medication at late stages. Prompt diagnosis assures the best outcome. Whereas the classic rash, erythema chronicum migrans, is pathognomonic, diagnosis in its absence may rest on serological tests. Bacteriological isolation is seldom successful and is lengthy (Shrestha et al, 1985). Since cloning of the DNA for several of B. burgdorferi antigens has been accomplished, utilization of hybridization techniques may allow rapid detection of the presence of the organism and confirm difficult cases in the future.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542350

Source DB:  PubMed          Journal:  Clin Rheum Dis        ISSN: 0307-742X


  7 in total

1.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi.

Authors:  G Zimmer; U E Schaible; M D Kramer; G Mall; C Museteanu; M M Simon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports.

Authors:  M R van der Linde; H J Crijns; J de Koning; J A Hoogkamp-Korstanje; J J de Graaf; D A Piers; A van der Galiën; K I Lie
Journal:  Br Heart J       Date:  1990-03

4.  Cardiac conduction abnormalities in a mouse model of Lyme borreliosis.

Authors:  S Saba; B A VanderBrink; G Perides; L J Glickstein; M S Link; M K Homoud; R T Bronson; M Estes ; P J Wang
Journal:  J Interv Card Electrophysiol       Date:  2001-06       Impact factor: 1.900

5.  Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.

Authors:  J Alder; M Mitten; K Jarvis; P Gupta; J Clement
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Intracellular localization of Borrelia burgdorferi within human endothelial cells.

Authors:  Y Ma; A Sturrock; J J Weis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  When antibiotics treat heart block.

Authors:  Loveena Lama; Ajay K Sharma; E Kevin Heist
Journal:  N Am J Med Sci       Date:  2012-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.